These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37449672)

  • 21. Transcriptome profiling reveals liver metastasis-associated genes in pancreatic ductal adenocarcinoma.
    Yu Y; Wang Z; Mo DH; Wang Z; Li G
    Math Biosci Eng; 2021 Feb; 18(2):1708-1721. PubMed ID: 33757206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes.
    de Koning W; Latifi D; Li Y; van Eijck CHJ; Stubbs AP; Mustafa DAM
    Front Immunol; 2021; 12():649061. PubMed ID: 33986743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma.
    Yang H; Zhang W; Ding J; Hu J; Sun Y; Peng W; Chu Y; Xie L; Mei Z; Shao Z; Xiao Y
    Front Immunol; 2022; 13():970588. PubMed ID: 36148233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of tumor-associated endothelial cells and the development of a prognostic model in pancreatic ductal adenocarcinoma.
    Wu J; Liu Y; Fu Q; Cao Z; Ma X; Li X
    Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130545. PubMed ID: 38141886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Immune Microenvironment on the Prognosis of Pancreatic Ductal Adenocarcinoma Based on Multi-Omics Analysis.
    Yang B; Zhou M; Wu Y; Ma Y; Tan Q; Yuan W; Ma J
    Front Immunol; 2021; 12():769047. PubMed ID: 34777388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
    Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
    Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LDHA is a prognostic biomarker on the immune response in pancreatic adenocarcinoma and associated with m6A modification.
    Tan Z; Liu J; Xu J; Zhang B; Yu X; Wang W; Liang C
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4853-4865. PubMed ID: 36269388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).
    Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M
    Front Immunol; 2022; 13():1060957. PubMed ID: 36591282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2016 Aug; 39(4):379-88. PubMed ID: 27240826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiling of morphologic subtypes of pancreatic ductal adenocarcinoma using surgical and EUS-FNB specimens.
    Rasmussen LG; Verbeke CS; Sørensen MD; Pfeiffer P; Tan Q; Mortensen MB; Fristrup C; Detlefsen S
    Pancreatology; 2021 Apr; 21(3):530-543. PubMed ID: 33637450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of Jagged1 as a dynamic switch of cancer cell plasticity in PDAC assembloids.
    Choi JI; Rim JH; Jang SI; Park JS; Park H; Cho JH; Lim JB
    Theranostics; 2022; 12(9):4431-4445. PubMed ID: 35673567
    [No Abstract]   [Full Text] [Related]  

  • 32. Neutrophil in the Pancreatic Tumor Microenvironment.
    Jin L; Kim HS; Shi J
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin.
    Espinet E; Gu Z; Imbusch CD; Giese NA; Büscher M; Safavi M; Weisenburger S; Klein C; Vogel V; Falcone M; Insua-Rodríguez J; Reitberger M; Thiel V; Kossi SO; Muckenhuber A; Sarai K; Lee AYL; Backx E; Zarei S; Gaida MM; Rodríguez-Paredes M; Donato E; Yen HY; Eils R; Schlesner M; Pfarr N; Hackert T; Plass C; Brors B; Steiger K; Weichenhan D; Arda HE; Rooman I; Kopp JL; Strobel O; Weichert W; Sprick MR; Trumpp A
    Cancer Discov; 2021 Mar; 11(3):638-659. PubMed ID: 33060108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy.
    Bärthel S; Falcomatà C; Rad R; Theis FJ; Saur D
    Nat Cancer; 2023 Apr; 4(4):454-467. PubMed ID: 36959420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-cell RNA-seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast-like giant-cells.
    Wang X; Miao J; Wang S; Shen R; Zhang S; Tian Y; Li M; Zhu D; Yao A; Bao W; Zhang Q; Tang X; Wang X; Li J
    Mol Cancer; 2022 Jun; 21(1):133. PubMed ID: 35733218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance and immune infiltration of microenvironment-related signatures in pancreatic cancer.
    Lu Q; Zhang Y; Chen X; Gu W; Ji X; Chen Z
    Medicine (Baltimore); 2021 Mar; 100(12):e24957. PubMed ID: 33761652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia and pancreatic ductal adenocarcinoma.
    Yamasaki A; Yanai K; Onishi H
    Cancer Lett; 2020 Aug; 484():9-15. PubMed ID: 32380129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of PDAC subtype heterogeneity and therapy response.
    Espinet E; Klein L; Puré E; Singh SK
    Trends Cancer; 2022 Dec; 8(12):1060-1071. PubMed ID: 36117109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An integrated study to decipher immunosuppressive cellular communication in the PDAC environment.
    Avşar G; Pir P
    NPJ Syst Biol Appl; 2023 Nov; 9(1):56. PubMed ID: 37945567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier.
    Bhasin MK; Ndebele K; Bucur O; Yee EU; Otu HH; Plati J; Bullock A; Gu X; Castan E; Zhang P; Najarian R; Muraru MS; Miksad R; Khosravi-Far R; Libermann TA
    Oncotarget; 2016 Apr; 7(17):23263-81. PubMed ID: 26993610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.